Daxor Overview

  • Status
  • Public
  • Employees
  • 750
Employees
  • Stock Symbol
  • DXR
Stock Symbol
  • Share Price
  • $9.49
  • (As of Friday Closing)

Daxor General Information

Description

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Contact Information

Website
www.daxor.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Biotechnology
Stock Exchange
ASE
Primary Office
  • 350 Fifth Avenue
  • Suite 4740
  • New York, NY 10118
  • United States
+1 (212) 000-0000

Daxor Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Daxor Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.49 $8.99 $8.62 - $24.08 $38.3M 4.03M 9.3K -$0.28

Daxor Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 51,076 51,076 39,618 34,938
Revenue (988) (988) 28 (797)
Net Income (1,705) (1,705) (496) (886)
Total Assets 16,553 16,553 14,201 17,627
Total Debt 171 171 1,343 4,455
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Daxor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Daxor‘s full profile, request access.

Request a free trial

Daxor Executive Team (4)

Name Title Board Seat Contact Info
Michael Feldschuh Chief Executive Officer & Chairman
Robert Michel Chief Financial Officer
Jonathan Feldschuh Board Member & Chief Strategy Officer, Strategy
You’re viewing 3 of 4 executive team members. Get the full list »

Daxor Board Members (4)

Name Representing Role Since
00000 0000000 Daxor Board Member 000 0000
00000000 000000000 Daxor Board Member & Chief Strategy Officer, Strategy 000 0000
0000000 000000000 Daxor Chief Executive Officer & Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Daxor Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial